Related Experiment Video
Updated: Aug 10, 2026

In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
Published on: August 16, 2013
Involvement of endogenous nitric oxide in myeloperoxidase mediated benzo(a)pyrene induced polymorphonuclear
Abhai Kumar1, Suman Patel, Yogendra Kumar Gupta
1Industrial Toxicology Research Centre (ITRC), Lucknow 226 001, UP, India.
Abstract:
The present study was undertaken to investigate the involvement of nitric oxide in the augmentation of benzo(a)pyrene induced cellular injury in polymorphonuclear leukocytes (PMNs). Polymorphs were isolated from the blood collected from Wistar rats treated with and without benzo(a)pyrene (50mg/kg, i.p.) through cardiac puncture. Catalase, superoxide dismutase (SOD), glutathione-s-transferase (GST), myeloperoxidase (MPO) and nitrite content were estimated in PMNs using standard procedures. Inducible nitric oxide synthase (iNOS) and cytochrome P-4501A1 (CYP1A1) expression in PMNs were also analyzed in presence or absence of nitric oxide synthase (NOS) inhibitors, aminoguanidine (AG, 5mM) and L-NG nitro L-arginine methyl ester (L-NAME, 1mM). A significant augmentation was observed in the nitrite content, activities of superoxide dismutase, MPO and GST and the expressions of iNOS and CYP1A1, however, catalase activity was attenuated in PMNs of benzo(a)pyrene treated rats as compared with their respective controls. AG and L-NAME resulted in a significant attenuation in nitrite content, MPO activity and iNOS expression; however, no significant alteration was observed in CYP1A1 expression. CYP1A1 inhibitor alpha-naphthoflavone inhibited the expression of iNOS in PMNs of benzo(a)pyrene treated animals significantly. The results obtained thus suggest that CYP1A1 induces iNOS expression leading to the generation of endogenous nitric oxide (NO) that could be responsible for the augmentation of myeloperoxidase-mediated benzo(a)pyrene-induced injury in PMNs.
Insights
Benzo(a)pyrene exposure increases cellular injury in polymorphonuclear leukocytes (PMNs) via nitric oxide (NO) production. Cytochrome P-450 1A1 (CYP1A1) appears to induce inducible nitric oxide synthase (iNOS) expression, contributing to this PMN damage.
Area of Science:
- Toxicology
- Biochemistry
- Immunology
Background:
- Benzo(a)pyrene is a polycyclic aromatic hydrocarbon known to cause cellular damage.
- Polymorphonuclear leukocytes (PMNs) play a crucial role in inflammatory and immune responses.
- Nitric oxide (NO) is a signaling molecule implicated in various cellular processes, including inflammation and injury.
Purpose of the Study:
- To investigate the role of nitric oxide (NO) in benzo(a)pyrene-induced cellular injury in PMNs.
- To elucidate the relationship between cytochrome P-450 1A1 (CYP1A1) and inducible nitric oxide synthase (iNOS) in this context.
Main Methods:
- PMNs were isolated from Wistar rats treated with or without benzo(a)pyrene.
- Enzyme activities (catalase, SOD, GST, MPO) and nitrite content were measured.
- Expression of iNOS and CYP1A1 was analyzed using NOS inhibitors (aminoguanidine, L-NAME) and a CYP1A1 inhibitor (alpha-naphthoflavone).
Main Results:
- Benzo(a)pyrene treatment significantly increased nitrite content, SOD, MPO, GST activities, and iNOS and CYP1A1 expression in PMNs.
- NOS inhibitors (AG, L-NAME) reduced nitrite content, MPO activity, and iNOS expression, but not CYP1A1 expression.
- CYP1A1 inhibition significantly decreased iNOS expression in benzo(a)pyrene-treated PMNs.
Conclusions:
- CYP1A1 induces iNOS expression, leading to endogenous NO generation.
- This NO production contributes to the augmentation of myeloperoxidase-mediated benzo(a)pyrene-induced injury in PMNs.
- The findings highlight a novel mechanism of benzo(a)pyrene toxicity involving CYP1A1-iNOS-NO pathway.
More Related Videos
Related Concept Videos
Electrophilic Aromatic Substitution: Nitration of Benzene
Nitric Oxide Signaling Pathway
Bioactivation and Tissue Toxicity
Reactions at the Benzylic Position: Oxidation and Reduction
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3

